Patents by Inventor Sivakumaran Meenakshisunderam

Sivakumaran Meenakshisunderam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions of Rimegepant
    Publication number: 20240358695
    Abstract: The present invention relates to rapidly disintegrating pharmaceutical composition comprising Rimegepant or pharmaceutically acceptable salt thereof, and processes for manufacture thereof.
    Type: Application
    Filed: April 23, 2024
    Publication date: October 31, 2024
    Applicant: Aurobindo Pharma Ltd
    Inventors: Sreekanth Manikonda, Avinash Reddy Manda, Siva Kumar Reddy Chamala, Nagaprasad Vishnubhotla, Sivakumaran Meenakshisunderam
  • PHARMACEUTICAL COMPOSITIONS OF LUMATEPERONE
    Publication number: 20240285618
    Abstract: The present disclosure relates to pharmaceutical composition comprising Lumateperone or pharmaceutically acceptable salt form and, processes for manufacture thereof.
    Type: Application
    Filed: February 20, 2024
    Publication date: August 29, 2024
    Inventors: Saravanan Kannusamy, Prabhakaran Chakkirala, Jagadeesh Gorsa, Nagaprasad Vishnubhotla, Sivakumaran Meenakshisunderam
  • Naloxegol oxalate and solid dispersion thereof
    Patent number: 11974996
    Abstract: The present invention relates to solid dispersion of Naloxegol oxalate. Further, the present invention relates to an improved process for Naloxegol oxalate and intermediates thereof.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: May 7, 2024
    Assignee: Aurobindo Pharma Ltd
    Inventors: Rama Shankar, Nimesh Chandra Misra, Siva Rama Kasibabu Velugula, Suresh Chapala, Sivakumaran Meenakshisunderam
  • Pharmaceutical compositions of deutetrabenazine and process for preparation thereof
    Patent number: 11969413
    Abstract: This present invention relates to pharmaceutical composition comprising Deutetrabenazine. The invention also relates to the methods of preparation of the composition having improved stability and dissolution profile and used for the treatment of chorea associated with Huntington disease and tardive dyskinesia.
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: April 30, 2024
    Assignee: Aurobindo Pharma Ltd
    Inventors: Saravanan Kannusamy, Prabhakaran Chakkirala, Nagaprasad Vishnubhotla, Sivakumaran Meenakshisunderam
  • Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof
    Patent number: 11857559
    Abstract: The present invention relates to a binder free stable pharmaceutical composition comprising amorphous canagliflozin or a pharmaceutically acceptable salt or a prodrug thereof, and one or more pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioavailability profile to that of INVOKANA® tablets.
    Type: Grant
    Filed: November 21, 2020
    Date of Patent: January 2, 2024
    Inventors: Satyabrata Barik, Venugopala Chokkasandra Jayarama Reddy, Sivakumaran Meenakshisunderam
  • PHARMACEUTICAL COMPOSITIONS OF UBROGEPANT AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20230390254
    Abstract: The present invention relates to a stable immediate release tablet compositions of Ubrogepant and one or more pharmaceutically acceptable excipients and a process for preparation thereof.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 7, 2023
    Inventors: Saravanan KANNUSAMY, Koteswararao GUDE, Nagaprasad VISHNUBHOTLA, Sivakumaran MEENAKSHISUNDERAM
  • EXTENDED RELEASE COMPOSITIONS OF PSEUDOEPHEDRINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20230248667
    Abstract: This invention relates to dosage forms comprising pseudoephedrine or a salt thereof, for extended-release up to 24 hours, and process of making such dosage forms. This invention provides a non-osmotic extended-release dosage form comprising pseudoephedrine hydrochloride which can be administered to patients who need and/or desire a decongestant medication up to 24 hours. This invention also relates to dosage forms comprising pseudoephedrine or a salt thereof and cetirizine or levocetirizine or its salts thereof for extended-release up to 24 hours, and process of making such dosage forms.
    Type: Application
    Filed: February 3, 2023
    Publication date: August 10, 2023
    Applicant: Aurobindo Pharma Ltd
    Inventors: Soumyajit Behera, Satheesh Kumar Gajjala, Nilesh Bhandari, Nagaprasad Vishnubhotla, Sivakumaran Meenakshisunderam
  • Pharmaceutical composition comprising pimavanserin, process of preparation and use thereof
    Patent number: 11648242
    Abstract: The present invention relates to prepare pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof, processes for manufacturing said pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof. Also pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: May 16, 2023
    Assignee: Aurobindo Pharma Ltd
    Inventors: Saravanan Kannusamy, Prabhakaran Chakkirala, Rakesh Sarkar, Sivakumaran Meenakshisunderam
  • Pharmaceutical compositions of Deutetrabenazine and process for preparation thereof
    Publication number: 20220409596
    Abstract: This present invention relates to pharmaceutical composition comprising Deutetrabenazine. The invention also relates to the methods of preparation of the composition having improved stability and dissolution profile and used for the treatment of chorea associated with Huntington disease and tardive dyskinesia.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 29, 2022
    Applicant: Aurobindo Pharma Ltd
    Inventors: Saravanan KANNUSAMY, Prabhakaran CHAKKIRALA, Nagaprasad VISHNUBHOTLA, Sivakumaran MEENAKSHISUNDERAM
  • Process for the preparation of lifitegrast
    Patent number: 11345683
    Abstract: The present invention provides dibenzylamine salt of Lifitegrast (XV), and diphenylamine salt of Lifitegrast (XVI) and the use of the above salts in the purification process of Lifitegrast (I). The present invention relates to a process for the preparation of Lifitegrast (I).
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: May 31, 2022
    Assignee: Aurobindo Pharma Ltd
    Inventors: Praveen Kumar Neela, Guruswamy Batthini, Vijay Kumar Gupta Gangisetty, Ravikanth Dupud, Srikanth Sai Alur, Sivakumaran Meenakshisunderam
  • A PROCESS FOR THE PREPARATION OF TRAMETINIB ACETIC ACID SOLVATE
    Publication number: 20220098192
    Abstract: The present invention relates to a process for the preparation of Trametinib acetic acid solvate (Ia): The present invention also directed towards a pharmaceutical composition comprising Trametinib acetic acid solvate (Ia) and optionally one or more pharmaceutically acceptable excipients or carriers.
    Type: Application
    Filed: February 6, 2020
    Publication date: March 31, 2022
    Inventors: Gangadhara Bhima Shankar NANGI, Ramadas CHAVAKULA, Venkata Rama Krishna Murthy MOTURU, Jyothi Sudharshan Chakradhar SALADI, Sandeep Kumar VADLA, Sadashiv JAGTAP, Sivakumaran MEENAKSHISUNDERAM
  • Stable cariprazine formulations for oral use
    Patent number: 11273156
    Abstract: The present invention relates to stabilized pharmaceutical formulations comprising therapeutically effective amount of Cariprazine premix/solid dispersion, or its pharmaceutically acceptable salts, esters, hydrates and solvates thereof, at least one diluent which is not having low water activity and optionally one or more excipients selected from lubricant, disintegrant and buffering agent or combinations thereof. The present invention further relates to process for preparation and method of using such stable formulations comprising Cariprazine.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: March 15, 2022
    Assignee: Aurobindo Pharma Ltd
    Inventors: Ankit Anand Kharia, Sunil Chowdary Koduri, Jaikishore Palepu, Nagaprasad Vishnubhotla, Sivakumaran Meenakshisunderam
  • Naloxegol Oxalate and Solid Dispersion thereof
    Publication number: 20210338660
    Abstract: The present invention relates to solid dispersion of Naloxegol oxalate. Further, the present invention relates to an improved process for Naloxegol oxalate and intermediates thereof.
    Type: Application
    Filed: June 18, 2021
    Publication date: November 4, 2021
    Applicant: Aurobindo Pharma Ltd
    Inventors: Rama Shankar, Nimesh Chandra Misra, Siva Rama Kasibabu Velugula, Suresh Chapala, Sivakumaran Meenakshisunderam
  • Process for the preparation of Eltrombopag olamine and its intermediates
    Patent number: 11161821
    Abstract: The present invention relates to an improved process for the purification of Eltrombopag olamine of compound of formula (2). The present invention also relates to an improved process for the preparation of Eltrombopag olamine intermediates and further conversion to Eltrombopag olamine of a compound of formula (2).
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: November 2, 2021
    Assignee: Aurobindo Pharma Ltd.
    Inventors: Moturu Venkata Ramakrishna Murthy, Tiwari Shashi Kant, Nadakudity Sailendra Kumar, Samala Bhanuchander, Rajesh Chennuri, Srinivasa Chary Katuroju, Sivakumaran Meenakshisunderam
  • Pharmaceutical composition of ivermectin and process for preparation thereof
    Patent number: 11160780
    Abstract: The invention relates to a topical pharmaceutical composition comprising effective amount of ivermectin as an active agent, process of preparation thereof and method of treating dermatological conditions such as inflammatory lesions of rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acne form rashes, and the like.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: November 2, 2021
    Assignee: Aurobindo Pharma Ltd.
    Inventors: Biswajit Saha, Nilendu Sen, Sivakumaran Meenakshisunderam
  • Pharmaceutical compositions of linagliptin and process for preparation thereof
    Patent number: 11096945
    Abstract: Pharmaceutical compositions comprising an antidiabetic agent as an active agent are provided. The present invention relates to pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof as an active agent. The present invention also relates to process of preparation of pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof. The present invention also relates to method of administering the compositions comprising linagliptin to a subject in need thereof.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: August 24, 2021
    Assignee: Aurobindo Pharma Ltd
    Inventors: Venugopala Chokkasandra Jayaramareddy, Sreenivas Reddy, Chandrashekhar Shriram Kandi, Sivakumaran Meenakshisunderam
  • Naloxegol oxalate and solid dispersion thereof
    Patent number: 11077103
    Abstract: The present invention relates to solid dispersion of Naloxegol oxalate. Further, the present invention relates to an improved process for Naloxegol oxalate and intermediates thereof.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: August 3, 2021
    Assignee: Aurobindo Pharma Ltd.
    Inventors: Rama Shankar, Nimesh Chandra Misra, Siva Rama Kasibabu Velegula, Suresh Chapala, Sivakumaran Meenakshisunderam
  • Process for the preparation of Deferasirox
    Patent number: 11078167
    Abstract: The present invention provides an improved process for the preparation of Deferasirox of Formula-I substantially free from ‘hydrazino impurity’ by the condensation of 2-(2-hydrophenyl)-4H-1,3-benzoxazin-4-one of Formula-IV with 4-hydrazino benzoic acid of Formula-V in a polar solvent.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: August 3, 2021
    Assignee: Aurobindo Pharma Ltd
    Inventors: Hero Velladurai, Janardhana Rao Vascuri, Ravi Shankar Sathu, Sivakumaran Meenakshisunderam
  • An improved process for the preparation of Eltrombopag Olamine and its intermediates
    Publication number: 20210230120
    Abstract: The present invention relates to an improved process for the purification of Eltrombopag olamine of compound of formula (2). The present invention also relates to an improved process for the preparation of Eltrombopag olamine intermediates and further conversion to Eltrombopag olamine of a compound of formula (2).
    Type: Application
    Filed: May 16, 2019
    Publication date: July 29, 2021
    Applicant: Aurobindo Pharma Ltd
    Inventors: Moturu Venkata Ramakrishna MURTHY, Tiwari Shashi KANT, Nadakudity Sailendra KUMAR, Samala BHANUCHANDER, Rajesh CHENNURI, Srinivasa Chary KATUROJU, Sivakumaran MEENAKSHISUNDERAM
  • PHARMACEUTICAL COMPOSITION COMPRISING PIMAVANSERIN, PROCESS OF PREPARATION AND USE THEREOF
    Publication number: 20210177822
    Abstract: The present invention relates to prepare pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof, processes for manufacturing said pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof. Also pharmaceutical compositions comprising pimavanserin or a pharmaceutically acceptable salt thereof for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 17, 2021
    Inventors: Saravanan Kannusamy, Prabhakaran Chakkirala, Rakesh Sarkar, Sivakumaran Meenakshisunderam